Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Protalix BioTherapeutics (PLX) Consolidated Net Income (2016 - 2025)

Protalix BioTherapeutics has reported Consolidated Net Income over the past 16 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$1.1 million for Q4 2025, down 109.77% from a year ago — trailing twelve months through Dec 2025 was -$2.1 million (down 127.77% YoY), and the annual figure for FY2025 was -$2.0 million, down 126.24%.
  • Consolidated Net Income for Q4 2025 was -$1.1 million at Protalix BioTherapeutics, down from $2.4 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for PLX hit a ceiling of $19.3 million in Q2 2023 and a floor of -$18.6 million in Q4 2023.
  • Median Consolidated Net Income over the past 5 years was -$3.2 million (2022), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Consolidated Net Income: crashed 2179.87% in 2021 and later soared 462.56% in 2023.
  • Protalix BioTherapeutics' Consolidated Net Income stood at -$6.6 million in 2021, then soared by 51.47% to -$3.2 million in 2022, then plummeted by 478.79% to -$18.6 million in 2023, then soared by 160.7% to $11.3 million in 2024, then plummeted by 109.77% to -$1.1 million in 2025.
  • The last three reported values for Consolidated Net Income were -$1.1 million (Q4 2025), $2.4 million (Q3 2025), and $164000.0 (Q2 2025) per Business Quant data.